Antibody against nucleocapsid protein predicts susceptibility to human coronavirus infection

Journal of Infection

Volumn 71, Issue 5, 2015, Pages 599-602

  Gao, Xin ^a   Zhou, Hongli ^a   Wu, Chao ^a   Xiao, Yan ^a   Ren, Lili ^a   Paranhos Baccalà, Gláucia ^b   Guo, Li ^a   Wang, Jianwei ^a  

^a INSTITUTE OF PATHOGEN BIOLOGY   (China)

^b Fondation Mérieux Applied Research   (France)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G ANTIBODY; NUCLEOCAPSID PROTEIN; NUCLEOCAPSID PROTEIN, CORONAVIRUS; VIRUS ANTIBODY;

ADOLESCENT; ADULT; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; CHILD; CONTROLLED STUDY; CORONAVIRUS INFECTION; CROSS REACTION; DISEASE PREDISPOSITION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; IMMUNOGENICITY; INFECTION RISK; INFECTION SENSITIVITY; LETTER; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; POLYMERASE CHAIN REACTION; RISK ASSESSMENT; SARS CORONAVIRUS; SEROPREVALENCE; SEVERE ACUTE RESPIRATORY SYNDROME; WESTERN BLOTTING; BLOOD; CHEMISTRY; CHINA; CORONAVIRIDAE; CORONAVIRUS INFECTIONS; FEMALE; IMMUNOLOGY; INFANT; MALE; MIDDLE AGED; NEWBORN; PRESCHOOL CHILD; VIROLOGY; YOUNG ADULT;

ADOLESCENT; ADULT; ANTIBODIES, VIRAL; CHILD; CHILD, PRESCHOOL; CHINA; CORONAVIRUS; CORONAVIRUS INFECTIONS; CROSS REACTIONS; DISEASE SUSCEPTIBILITY; FEMALE; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; MIDDLE EAST RESPIRATORY SYNDROME CORONAVIRUS; NUCLEOCAPSID PROTEINS; SARS VIRUS; SEROEPIDEMIOLOGIC STUDIES; SEVERE ACUTE RESPIRATORY SYNDROME; YOUNG ADULT;

EID: 84945478075     PISSN: 01634453     EISSN: 15322742     Source Type: Journal    
DOI: 10.1016/j.jinf.2015.07.002     Document Type: Letter

References (8)

1. Du L., Ma C., Jiang S. Antibodies induced by receptor-binding domain in spike protein of SARS-CoV do not cross-neutralize the novel human coronavirus hCoV-EMC. J Infect 2013, 67:348-350.
2. Lai M.M.C., Perlman S., Anderson L.J. Coronaviridae. Fields virology 2007, vol. 1:1306-1336. Lippincott Williams & Wilkins, Philadelphia. 5th ed.
3. Timani K.A., Ye L., Ye L., Zhu Y., Wu Z., Gong Z. Cloning, sequencing, expression, and purification of SARS-associated coronavirus nucleocapsid protein for serodiagnosis of SARS. J Clin Virol 2004, 30:309-312.
4. Sastre P., Dijkman R., Camuñas A., Ruiz T., Jebbink M.F., van der Hoek L., et al. Differentiation between human coronaviruses NL63 and 229E using a novel double-antibody sandwich enzyme-linked immunosorbent assay based on specific monoclonal antibodies. Clin Vaccin Immunol 2011, 18:113-118.
5. Agnihothram S., Gopal R., Yount B.L., Donaldson E.F., Menachery V.D., Graham R.L., et al. Evaluation of serologic and antigenic relationships between middle eastern respiratory syndrome coronavirus and other coronaviruses to develop vaccine platforms for the rapid response to emerging coronaviruses. J Infect Dis 2014, 209:995-1006.
6. Guo L., Wang Y., Zhou H., Wu C., Song J., Li J., et al. Differential seroprevalence of human bocavirus species 1-4 in Beijing, China. PLoS One 2012, 7:e39644.
7. Kean J.M., Rao S., Wang M., Garcea R.L. Seroepidemiology of human polyomaviruses. PLoS Pathog 2009, 5:e1000363.
8. Hustedt J.W., Christie C., Hustedt M.M., Esposito D., Vazquez M. Seroepidemiology of human bocavirus infection in Jamaica. PLoS One 2012, 7:e38206.